Luiz Arnaldo Szutan

Luiz Arnaldo Szutan

Auto-generated profile, based on publicly available information

Luiz Arnaldo Szutan

Irmandade da Santa Casa de Misericordia de Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RSRoberto Gomes da Silva
Roberto Gomes da Silva
MMMaria Luiza Queiroz de Miranda
Maria Luiza Queiroz de Miranda
PBPaulo Eugênio de Araújo Caldeira Brant
Paulo Eugênio de Araújo Caldeira Brant
PSPerla Oliveira Schulz
Perla Oliveira Schulz
MNMaria de Fátima Araujo Nascimento
Maria de Fátima Araujo Nascimento
LSLuiz Arnaldo Szutan
Luiz Arnaldo Szutan
Objective: Identifying significant fibrosis is crucial to evaluate the prognosis and therapeutic interventions in patients with nonalcoholic fatty liver disease (NAFLD). We assessed the performance of acoustic radiation force impulse (ARFI) elastography, APRI, FIB-4, Forns, NFS and BARD scores in determining liver fibrosis in severe obesity. Subjects and methods: A prospective study included 108 patients undergoing bariatric surgery. Liver biopsy specimens were obtained intraoperatively and classified according to the NAFLD Activity Score. Patients were assessed with serological markers and [...] ABSTRACT Objective: Identifying significant fibrosis is crucial to evaluate the prognosis and therapeutic interventions in patients with nonalcoholic fatty liver disease (NAFLD). We assessed the performance of acoustic radiation force impulse (ARFI) elastography, APRI, FIB-4, Forns, NFS and BARD scores in determining liver fibrosis in severe obesity. Subjects and methods: A prospective study included 108 patients undergoing bariatric surgery. Liver biopsy specimens were obtained intraoperatively and classified according to the NAFLD Activity Score. Patients were assessed with serological markers and

1 April 2016 in HPB
Verified
Journal Article
Closed access
GMG.F.S.D. Macedo
G.F.S.D. Macedo
EAE.M.D.C. Aranzana
E.M.D.C. Aranzana
MRM.A. Ribeiro
M.A. Ribeiro
LSL.A. Szutan
L.A. Szutan
FFF.G. Ferreira
F.G. Ferreira

1 March 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
CFCaroline Petersen da Costa Ferreira
Caroline Petersen da Costa Ferreira
MRMauricio Alves Ribeiro
Mauricio Alves Ribeiro
LSLuiz Arnaldo Szutan
Luiz Arnaldo Szutan
SUMMARY Malignant liver tumors are the fourth leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) accounts for 75-85% of these. Most patients are diagnosed at incurable stages. Palliative care is the appropriate treatment course in these circumstances (chemoembolization and sorafenib). There are few national studies on sorafenib. The objective is to evaluate survival predictors of HCC patients treated with sorafenib and evaluate the compliance of its indication in relation to BCLC recommendations. METHODS A total of 88 patients with an indication of sorafenib from 2010 to 2017 at the ISCMSP were retrospectively analyzed. Univariate and multivariate analyzes were performed in the search for predictors of survival. RESULTS The mean age was 61.2 years, 70.5% were men, most were classified as Child-Pugh A (69.3%), and BCLC C (94.3%). Cirrhosis was present in 84.6% and portal hypertension in 55.7%. Hepatitis C virus was the most common etiology (40.9%). Sixty-nine (78.4%) patients received the medication, with the average duration of treatment being 9.7 months. The mean overall survival was 16.8 months. Significant differences were observed in the multivariate analysis: ECOG PS (p = 0.024): Child-Pugh (p = 0.013), time of medication use (p <0.001), clinical worsening (p = 0.031) and portal thrombosis (p = 0.010). CONCLUSION Absence of portal thrombosis, Child-Pugh A, longer time of medication use, ECOG PS 0, and absence of suspension due to clinical worsening were predictors of better overall survival in the study. The drug’s indication complies with BCLC guidelines in 94% of patients.

2 January 2021 in Surgical Innovation
Verified
Journal Article
Open access
PDF file
PAPhillipe Abreu
Phillipe Abreu
RFRaphaella De Paula Ferreira
Raphaella De Paula Ferreira
VMVictor Mineli
Victor Mineli
DBDanilo S. Bussyguin
Danilo S. Bussyguin
LDLuiz B. Dantas
Luiz B. Dantas
FTFlavio D. S. Tomasich
Flavio D. S. Tomasich
Objectives. Endoscopic gastrostomy occasionally presents limitations such as costs, availability of equipment and special materials, and difficult access to the gastric cavity in the setting of obstructive esophageal tumors. Open jejunostomies present high rates of postoperative complications and limited capacity for abdominal evaluation due to reduced incision size. Thus, to reduce procedure-related complications and overall costs and provide a thorough intraoperative evaluation of the peritoneal cavity, we present the following simplified technique. Methods. Video-assisted jejunostomy in ten steps. Results. The use of this Video-assisted laparoscopic technique proves to be a safe, viable alternative, with cost reduction, decreased use of disposable materials, shortened operative time, and accelerated recovery, in addition to increased technical ease and wide applicability across a variety of hospital settings.

1 January 2026 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
FCFelipe José Fernández Coimbra
Felipe José Fernández Coimbra
AGAndré Luís de Godoy
André Luís de Godoy
PFPaulo Henrique de Sousa Fernandes
Paulo Henrique de Sousa Fernandes
HNHeládio Feitosa Neto
Heládio Feitosa Neto
RPRodrigo Nascimento Pinheiro
Rodrigo Nascimento Pinheiro
AOAlexandre Ferreira Oliveira
Alexandre Ferreira Oliveira
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with a rising incidence largely driven by chronic liver disease. Accurate diagnosis and appropriate clinical assessment at the time of presentation are essential, as therapeutic strategies and prognosis depend on tumor burden, liver function, portal hypertension, and patient performance status. Aim: To develop evidence-based, multidisciplinary recommendations to guide the diagnosis, clinical assessment, and staging of patients with HCC. Methods: This consensus was developed by 43 experts from surgical oncology, hepatology, clinical oncology, radiology, interventional radiology, pathology, liver transplantation, gastroenterology, radiation oncology, and palliative care, under the coordination of the Brazilian Society of Surgical Oncology and 13 collaborating national medical societies. A scientific steering committee predefined clinically relevant questions addressing radiological and histopathological diagnosis, clinical assessment, diagnostic work-up, management of patients at the time of HCC diagnosis, and staging. These questions were discussed and refined in multidisciplinary meetings and submitted to structured voting rounds. Results: The panel formulated 18 recommendations covering key aspects of HCC evaluation, including standardized application of Liver Imaging Reporting and Data System (LI-RADS®) for imaging-based diagnosis, management of indeterminate lesions, indications for biopsy, histopathological classification and reporting, immunohistochemical markers, assessment of hepatic function and portal hypertension, staging systems, diagnostic work-up, and the role of multidisciplinary care. The recommendations emphasize integration of imaging findings with liver-related factors and clinical context to support individualized decision-making. Conclusions: This multidisciplinary consensus provides practical, evidence-based recommendations for the diagnosis, clinical assessment, and staging of HCC. By promoting standardized diagnostic practices while reinforcing comprehensive patient evaluation and multidisciplinary management, this document aims to improve diagnostic accuracy, optimize treatment selection, and support safe care.

17 January 2019 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
AFAlexandre Fioranelli
Alexandre Fioranelli
CSCharles Schmidt
Charles Schmidt
NWNelson Wolosker
Nelson Wolosker
VCValter Castelli
Valter Castelli
DLDafne Braga Diamante Leiderman
Dafne Braga Diamante Leiderman
LSLuiz Arnaldo Szutan
Luiz Arnaldo Szutan
To analyze the leadership potential of physicians in a public hospital in the city of São Paulo. A descriptive pilot study, in which 40 assistant physicians and medical residents were randomly selected to receive an electronic invitation of the company Caliper Estratégias Humanas do Brasil . To those who accepted it, a link was sent to fill out a personality evaluation focused on the work, comprising 112 alternatives related to 21 domains of 4 performance areas. According to the Caliper Profile Questionnaire, the ipsative measures expressed as a percentage are distributed on a Likert scale, and three categories are established based on behavioral tendencies at work: need for improvement, moderate and high potential. A total of 47.5% of physicians invited accepeted taking part in the study. Regarding to leadership, the need for improvement was over 30% among the evaluated physicians. In the interpersonal relationship analysis, only 18.4% of assistant physicians and 37% of medical residents required improvement. The percentage of physicians who needed improvement in problem-solving and decision-making was similar among the assistant and resident physicians (12.6% versus 14%). In the evaluation of personal organization and time management, we obtained similar percentages in assistant physicians and residents who needed improvement (14% in both groups). High potential leadership was observed in these domains (18.4% and 20% for assistant physicians and residents, respectively). The physicians assessed presented high leadership potential in 25% of the cases, requiring improvement in the performance domains, such as interpersonal relationship, problem solving, decision-making, personal organization and time management.